To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III)
Clinical trial NCT01072942 · COMPLETED
Trial details
- NCT number
- NCT01072942
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-06-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.